Literature DB >> 7606641

Restenosis after transluminal coronary angioplasty: a risk factor analysis.

A Gürlek1, Z Dağalp, D Oral, K Omürlü, C Erol, T Akyol, E Tutar.   

Abstract

BACKGROUND: Restenosis after percutaneous transluminal coronary angioplasty (PTCA) is a major problem limiting the long-term efficacy of the procedure. The purpose of this study was to determine whether risk factors such as cigarette smoking, diabetes mellitus, hypertension or hypercholesterolaemia correlate with restenosis after PTCA. We also studied the relationship between a history of previous myocardial infarction and the extent of coronary artery disease (single-, two- or three-vessel) with restenosis after coronary angioplasty.
METHODS: A total of 360 patients underwent successful PTCA. Follow-up coronary angiograms were performed in 181 patients after a mean +/- SD period of 6 +/- 4 months.
RESULTS: The restenosis rate was 49%. We divided the patients into two groups: 89 patients with restenosis (8 women and 81 men) and 92 patients with no restenosis (14 women and 78 men). Age, sex, a history of cigarette smoking, diabetes mellitus and a history of previous myocardial infarction were not associated with restenosis. Serum levels of triglyceride were also unrelated to the restenosis rate. Restenosis was associated with hypertension, low levels of high-density-lipoprotein cholesterol, high levels of low-density-lipoprotein cholesterol and high total cholesterol levels (P < 0.001). Patients with two-vessel or multivessel disease had significantly higher restenosis rates than patients with single-vessel disease (P < 0.001).
CONCLUSION: Patients with hyperlipidaemia, hypertension and multi-vessel disease appear to be higher risk of recurrent restenosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7606641

Source DB:  PubMed          Journal:  J Cardiovasc Risk        ISSN: 1350-6277


  9 in total

1.  Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double-injury model.

Authors:  Y Inoue; K Toga; T Sudo; K Tachibana; S Tochizawa; Y Kimura; Y Yoshida; H Hidaka
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Overcommitment predicts restenosis after coronary angioplasty in cardiac patients.

Authors:  L Joksimovic; J Siegrist; M Meyer-Hammer; R Peter; B Franke; W J Klimek; M P Heintzen; B E Strauer
Journal:  Int J Behav Med       Date:  1999

3.  Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice.

Authors:  C Napoli; G Cirino; P Del Soldato; R Sorrentino; V Sica; M Condorelli; A Pinto; L J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

4.  Flow-mediated vascular remodeling in hypertension: relation to hemodyamics.

Authors:  Jamila Ibrahim; Bradford C Berk
Journal:  Stroke       Date:  2008-12-18       Impact factor: 7.914

5.  Does lipoprotein (a) level have a predictive value in restenosis after coronary stenting?

Authors:  Alireza Khosravi; Masoud Pourmoghaddas; Fereshteh Ziaie; Arezoo Enteshari; Arsalan Khaledifa; Ahmad Bahonar
Journal:  Int J Prev Med       Date:  2011-07

6.  Investigation factors affecting the first recurrence of coronary artery disease in patients undergone angioplasty using cox survival model.

Authors:  Javad Nasseryan; Ebrahim Hajizadeh; Aliakbar Rasekhi; Hassan Ahangar
Journal:  Med J Islam Repub Iran       Date:  2016-11-08

7.  Evaluation and efficacy of long length Pronova XR Bioabsorbable Polymer stent in the treatment of long coronary lesions.

Authors:  M S Hiremath
Journal:  Indian Heart J       Date:  2017-06-23

8.  Fisetin Alleviates Neointimal Hyperplasia via PPARγ/PON2 Antioxidative Pathway in SHR Rat Artery Injury Model.

Authors:  Fang Pei; Hua Pei; Chunhua Su; Lin Du; Jifen Wang; Fusheng Xie; Qi Yin; Zhao Gao
Journal:  Oxid Med Cell Longev       Date:  2021-04-21       Impact factor: 6.543

9.  Frequency of recurrence of peripheral artery disease among angioplasty and stenting patients.

Authors:  Alireza Gheini; Amir Shakarami; Parsa Namdari; Mehrdad Namdari; Ali Pooria
Journal:  Ann Med Surg (Lond)       Date:  2021-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.